1. Magnesium and the risk of all-cause and cardiac mortality in hemodialysis patients: agent provocateur or innocent bystander? 
Cecile Courivaud, Andrew Davenport 
Kidney International 
Volume 85, Issue 1, Pages (January 2014)
DOI: /ki
Copyright © 2014 International Society of Nephrology Terms and Conditions

2. Figure 1
Cartoon proposing links between a higher mortality and hypomagnesemia/hypermagnesemia in hemodialysis patients. (a) Hypomagnesemia is commonly associated with increased co-morbidity, and also induces pro-atherosclerotic and pro-thrombotic phenotypes and mineralizing disorders. Moreover, hypomagnesemia is associated with high blood pressure and a higher risk of cardiac arrhythmia. (b) Mild hypermagnesemia may have protective vascular effects, whereas moderate hypermagnesemia reduces osteoid formation and over-supresses PTH leading to vascular calcifications. LDL chol, low-density lipoprotein cholesterol; PTH, parathyroid hormone; TG, triglycerides.
Kidney International  , 17-20DOI: ( /ki )
Copyright © 2014 International Society of Nephrology Terms and Conditions

3. Figure 2
Intra-patient variability in serum magnesium in 150 stable dialysis outpatients with 4 or more serum magnesium measurements. Data expressed as mean±s.d.
Kidney International  , 17-20DOI: ( /ki )
Copyright © 2014 International Society of Nephrology Terms and Conditions